Valuation: Novartis AG

Market Cap 302B 265B 247B 227B 425B 28,903B 436B 2,935B 1,148B 14,302B 1,133B 1,108B 49,443B P/E 2026 *
22.7x
P/E 2027 * 19.3x
Enterprise Value 335B 294B 275B 252B 472B 32,075B 483B 3,257B 1,274B 15,872B 1,257B 1,230B 54,868B EV / Sales 2026 *
5.82x
EV / Sales 2027 * 5.39x
Free-Float
91.66%
Yield 2026 *
2.74%
Yield 2027 * 2.86%
1 day-0.73%
1 week+3.35%
Current month+2.50%
1 month+2.74%
3 months+13.09%
6 months+13.61%
Current year+18.38%
1 week 122.56
Extreme 122.56
131.5
1 month 121.06
Extreme 121.06
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 91.56
Extreme 91.56
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Chief Tech/Sci/R&D Officer 64 15/05/2022
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap.
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%+3.35%+39.00%+43.76% 303B
-0.87%+2.94%+49.73%+163.92% 1,089B
-0.45%+5.95%+59.75%+52.18% 643B
+0.04%+2.81%+39.67%+74.54% 465B
-1.69%+8.36%+38.80%+34.26% 359B
+1.50%+5.14%+21.72%+18.77% 267B
+0.79%+4.32%-25.07%-36.02% 226B
-1.39%+5.78%+28.59%+63.91% 212B
-1.18%+1.88%+17.43%+72.69% 167B
-0.40%+0.84%+3.46%-30.27% 144B
Average -0.21%+3.44%+27.31%+45.77% 387.5B
Weighted average by Cap. -0.12%+3.29%+37.77%+74.94%

Financials

2026 *2027 *
Net sales 57.58B 50.6B 47.23B 43.35B 81.14B 5,516B 83.14B 560B 219B 2,729B 216B 212B 9,435B 61.12B 53.71B 50.13B 46.01B 86.13B 5,855B 88.25B 594B 232B 2,897B 229B 225B 10,015B
Net income 13.78B 12.11B 11.3B 10.37B 19.42B 1,320B 19.9B 134B 52.42B 653B 51.74B 50.62B 2,258B 15.36B 13.49B 12.6B 11.56B 21.64B 1,471B 22.17B 149B 58.41B 728B 57.66B 56.41B 2,516B
Net Debt 33.11B 29.1B 27.16B 24.93B 46.66B 3,172B 47.81B 322B 126B 1,570B 124B 122B 5,426B 27.82B 24.44B 22.82B 20.94B 39.2B 2,664B 40.16B 271B 106B 1,318B 104B 102B 4,558B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
29/07/26 CHF 129.74 -0.51% 2,331,609
28/07/26 CHF 130.40 +1.46% 2,558,238
27/07/26 CHF 128.52 +1.28% 2,435,055
24/07/26 CHF 126.90 -0.60% 1,859,367
23/07/26 CHF 127.66 +1.85% 2,482,939
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
158.18USD
Average target price
153.99USD
Spread / Average Target
-2.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock